phosphatidylcholines has been researched along with Leishmaniasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birchmore, JL; Hanson, PK; Malone, L; Nichols, JW | 1 |
| Barratt, G; Legrand, P | 1 |
1 review(s) available for phosphatidylcholines and Leishmaniasis
| Article | Year |
|---|---|
Comparison of the efficacy and pharmacology of formulations of amphotericin B used in treatment of leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Drug Combinations; Humans; Leishmaniasis; Liposomes; Multicenter Studies as Topic; Phosphatidylcholines; Phosphatidylglycerols | 2005 |
1 other study(ies) available for phosphatidylcholines and Leishmaniasis
| Article | Year |
|---|---|
Lem3p is essential for the uptake and potency of alkylphosphocholine drugs, edelfosine and miltefosine.
Topics: Alleles; Antiprotozoal Agents; Biological Transport; Cell Division; Cell Membrane; Cycloheximide; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple; Endocytosis; Gene Deletion; Ketoconazole; Leishmaniasis; Lipid Metabolism; Lysophosphatidylcholines; Membrane Transport Proteins; Microscopy, Fluorescence; Mutation; Nuclear Envelope; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Phosphodiesterase Inhibitors; Phospholipid Ethers; Phosphorylcholine; Point Mutation; Protein Structure, Tertiary; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Time Factors | 2003 |